🔎 Trials Near Me

Utama › Limfoma Hodgkin › New Jersey

Kajian klinikal Limfoma Hodgkin di New Jersey

5 kajian untuk Limfoma Hodgkin sedang mencari peserta di lokasi di New Jersey.

Bandar di New Jersey

Teks kajian rasmi (Bahasa Inggeris)

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT03618550

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Hackensack University Medical Center, Hackensack
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

  • Hackensack University Medical Center, Hackensack
Mengambil pesertaKajian pemerhatian
Umur 8 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06098430

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Apr 2026 · NCT06377566

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Wanita · Dikemas kini 4 Mac 2026 · NCT01788839

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.